Welcome to Drawbridge Pharmaceuticals

Drawbridge Pharmaceuticals is a privately-held company developing neuroactive steroid compounds for use in critical care situations.  The properties of these compounds include anaesthesia and sedation, anticonvulsant activity and neuroprotection. Phaxan™, the lead compound, is a fast onset and offset intravenous general anaesthetic and sedative that protects the brain from the harmful effects of insults such as hypoxia and trauma.  Phaxan™ has the highest therapeutic safety margin ever described for any anaesthetic drug.